VEPPANU™ is the first-and-only FDA-approved PROTAC, a type of heterobifunctional protein degrader –– Approval received in advance of ...

A Cyprus-based research and innovation team developing an AI-powered oncology software platform called Prognostic has outlined its progress, goals and challenges in an exclusive interview with the ...

Sept 17 (Reuters) - Drug developer Arvinas (ARVN.O), opens new tab said on Wednesday it will grant commercialization rights of an experimental breast cancer treatment it was developing with Pfizer ...

China has potentially revolutionized cancer therapy by producing Yttrium-90, a powerful beta-emitting isotope used to target liver tumors, using a commercial heavy-water reactor at the Qinshan Nuclear ...

Oral mucositis is a painful and debilitating condition linked to the side effects of chemotherapy and head and neck radiation ...